newsfilter
← Latest News
GlobeNewswire·

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

  • Cullinan Therapeutics, Inc. (NASDAQ: CGEM) announced its management team will attend upcoming investor conference fireside chats.
  • CEO Nadim Ahmed & CMO Jeffrey Jones will present at the Stifel 2026 Healthcare Conference in New York on November 10, 2026, at 2:40 p.m. ET.
  • The same executives will present at the UBS Global Biopharma Conference 2026 in London on November 17, 2026, at 2:00 p.m. GMT (9:00 a.m. ET).
  • Webcasts for both events will be available on the company's investor relations website under the Events and Presentations section.
  • Cullinan is a clinical-stage biopharmaceutical company focused on disease-modifying T cell engagers for autoimmune diseases & cancer.